Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Dong Wha Pharm Co., Ltd. (000020) Price & Analysis

000020 Stock Chart & Stats

₩5,100.00-₩60.00(-1.16%)
At close: 4:00 PM EDT
KRW 4,750KRW 5,000KRW 5,250KRW 5,5003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 5,020.00 - KRW 5,210.00
52-Week Range
KRW 4,450.00 - KRW 7,560.00
Previous Close
KRW 5,160.00
Volume
N/A
Average Volume (3M)
390.90K
Market Cap
KRW 141.36B
Enterprise Value
KRW 250.82B
Total Cash (Recent Filing)
KRW 32.45B
Total Debt (Recent Filing)
KRW 123.64B
Price to Earnings (P/E)
7.8
Beta
-0.01
Next Earnings
Nov 18, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
4.80%

Bulls Say, Bears Say

Bulls Say

Balance Sheet

Moderate leverage and steadily growing equity provide a relatively sound financial foundation for the pharmaceutical business. This balance-sheet resilience can support ongoing operations and product investment while reducing vulnerability to earnings weakness compared with a highly leveraged structure.

Gross Margin

Positive revenue growth combined with a gross margin near 42% indicates the company retains meaningful economics on its products. If maintained, this gross-profit base can fund commercialization and development activities even while overall earnings remain comparatively modest.

Operating Cash Flow

Positive and improving operating cash flow shows that the underlying business is generating cash from operations despite uneven earnings. Continued improvement would strengthen internal funding capacity and could help the company support investment without relying as heavily on external financing.

Bears Say

Free Cash Flow

Negative free cash flow means operating cash generation has not yet covered the company’s cash investment and other outflows. Until this improves, internally generated funds may be insufficient to support growth consistently, limiting financial flexibility and weakening the quality of reported earnings.

Profitability Volatility

Low current profitability and recent earnings volatility make the company’s earnings power less dependable than its gross margin alone suggests. The sharp decline from 2023 profitability, including an operating loss in 2025, raises concern that margins may not remain durable across reporting periods.

Capital Returns

Falling returns on equity alongside higher leverage suggests the capital base is currently being used less efficiently than in earlier years. Increased debt also reduces flexibility if earnings weaken again, potentially constraining investment and making recovery in profitability more important.

000020 FAQ

What was Dong Wha Pharm Co., Ltd.’s price range in the past 12 months?
Dong Wha Pharm Co., Ltd. lowest stock price was ₩4450.00 and its highest was ₩7560.00 in the past 12 months.
What is Dong Wha Pharm Co., Ltd.’s market cap?
Dong Wha Pharm Co., Ltd.’s market cap is ₩141.36B.
When is Dong Wha Pharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dong Wha Pharm Co., Ltd.’s earnings last quarter?
Dong Wha Pharm Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩239.739 earnings per share for the quarter.
Is Dong Wha Pharm Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Dong Wha Pharm Co., Ltd. pay dividends?
Dong Wha Pharm Co., Ltd. pays a ― dividend of ₩65 which represents an annual dividend yield of 4.8%. See more information on Dong Wha Pharm Co., Ltd. dividends here
What is Dong Wha Pharm Co., Ltd.’s EPS estimate?
Dong Wha Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dong Wha Pharm Co., Ltd. have?
Dong Wha Pharm Co., Ltd. has 27,931,470 shares outstanding.
What happened to Dong Wha Pharm Co., Ltd.’s price movement after its last earnings report?
Dong Wha Pharm Co., Ltd. reported an EPS of ₩239.739 in its last earnings report. Following the earnings report the stock price went up 3.307%.
Which hedge fund is a major shareholder of Dong Wha Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:000020
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology